A novel selenonucleoside suppresses tumor growth by targeting Skp2 degradation in paclitaxel-resistant prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel selenonucleoside suppresses tumor growth by targeting Skp2 degradation in paclitaxel-resistant prostate cancer

Published:2018-12 Issue: Volume:158 Page:84-94
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Byun Woong Sub,Jin Minkyung,Yu Jinha,Kim Won Kyung,Song Jayoung,Chung Hwa-Jin,Jeong Lak Shin,Lee Sang Kook

Funder

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference38 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J. Clin.,2016

2. Skp2: a novel potential therapeutic target for prostate cancer;Wang;Biochim. Biophys. Acta,2012

3. Regulation of paclitaxel sensitivity in prostate cancer cells by PTEN/maspin signaling;Gan;Oncol. Lett.,2017

4. Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation;Yusuf;Curr. Cancer Drug Targets,2003

5. Mechanism of paclitaxel resistance in a human prostate cancer cell line, PC3-PR, and its sensitization by cabazitaxel;Sobue;Biochem. Biophys. Res. Commun.,2016

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alkaloids from Zanthoxylum nitidum and their anti-proliferative activity against A549 cells by regulating the EGFR/AKT/mTOR pathway;Natural Product Research;2024-04-29

2. Repurposing Synthetic Congeners of a Natural Product Aurone Unveils a Lead Antitumor Agent Inhibiting Folded P-Loop Conformation of MET Receptor Tyrosine Kinase;Pharmaceuticals;2023-11-13

3. Skp2-mediated MLKL degradation confers cisplatin-resistant in non-small cell lung cancer cells;Communications Biology;2023-08-02

4. Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies;Biomedicine & Pharmacotherapy;2023-04

5. Pan-Cancer Analysis of the Expression and Prognostic Value of S-Phase Kinase-Associated Protein 2;Open Access Macedonian Journal of Medical Sciences;2023-01-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3